Spero Therapeutics Inc (SPRO)
1.175
-0.02
(-1.26%)
USD |
NASDAQ |
Nov 22, 15:47
Spero Therapeutics Price to Book Value: 0.9779 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 0.9904 |
| November 20, 2024 | 0.9987 |
| November 19, 2024 | 0.9654 |
| November 18, 2024 | 0.9488 |
| November 15, 2024 | 0.9821 |
| November 14, 2024 | 1.040 |
| November 13, 2024 | 1.090 |
| November 12, 2024 | 1.099 |
| November 11, 2024 | 1.107 |
| November 08, 2024 | 1.099 |
| November 07, 2024 | 1.090 |
| November 06, 2024 | 1.090 |
| November 05, 2024 | 1.086 |
| November 04, 2024 | 1.070 |
| November 01, 2024 | 0.9784 |
| October 31, 2024 | 1.020 |
| October 30, 2024 | 1.070 |
| October 29, 2024 | 1.086 |
| October 28, 2024 | 1.070 |
| October 25, 2024 | 1.103 |
| October 24, 2024 | 1.045 |
| October 23, 2024 | 1.045 |
| October 22, 2024 | 1.053 |
| October 21, 2024 | 1.061 |
| October 18, 2024 | 1.061 |
| Date | Value |
|---|---|
| October 17, 2024 | 1.065 |
| October 16, 2024 | 1.028 |
| October 15, 2024 | 0.995 |
| October 14, 2024 | 1.020 |
| October 11, 2024 | 1.036 |
| October 10, 2024 | 1.028 |
| October 09, 2024 | 1.028 |
| October 08, 2024 | 1.028 |
| October 07, 2024 | 1.078 |
| October 04, 2024 | 1.078 |
| October 03, 2024 | 1.070 |
| October 02, 2024 | 1.086 |
| October 01, 2024 | 1.086 |
| September 30, 2024 | 1.111 |
| September 27, 2024 | 0.8796 |
| September 26, 2024 | 0.8594 |
| September 25, 2024 | 0.8594 |
| September 24, 2024 | 0.8594 |
| September 23, 2024 | 0.8728 |
| September 20, 2024 | 0.893 |
| September 19, 2024 | 0.9098 |
| September 18, 2024 | 0.8997 |
| September 17, 2024 | 0.893 |
| September 16, 2024 | 0.9198 |
| September 13, 2024 | 0.9198 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4053
Minimum
Jun 28 2022
6.950
Maximum
Sep 23 2021
2.384
Average
2.318
Median
Dec 03 2019
Price to Book Value Benchmarks
| Arbutus Biopharma Corp | 6.178 |
| Equillium Inc | 1.117 |
| NovaBay Pharmaceuticals Inc | 3.142 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.340 |
Price to Book Value Related Metrics
| PE Ratio | 14.69 |
| PS Ratio | 0.7053 |
| PEG Ratio | 0.0210 |
| Price | 1.175 |
| Earnings Yield | 6.81% |
| Market Cap | 64.06M |
| PEGY Ratio | 0.0210 |
| Normalized PE Ratio | 14.69 |